Correlation between clinicopathological background and p53 mutation status as well as NF-κB, Fascin, and E-cadherin expression in tumor specimens from 75 colorectal adenocarcinoma patients. This evidence concerns the gene FSCN1 and colorectal adenocarcinoma.